乳腺癌患者内分泌治疗依从性和服药信念的现状及相关性研究

发布时间：2018-05-04 01:31

本文选题：乳腺癌 + 内分泌治疗　；参考：《中国医科大学学报》2017年08期

【摘要】：目的分析乳腺癌患者内分泌治疗的服药依从性和服药信念现状及两者的相关性。方法选取沈阳市某三级甲等医院乳腺癌术后并接受内分泌治疗第1年的237例患者,通过发放Morisky服药依从性问卷和BMQ服药信念问卷,对患者服药依从性与服药信念的现状进行描述性和多元回归分析。结果 237例患者的MMAS-8问卷平均(6.39±1.68)分,服药依从性为65%;BMQ量表平均(-0.02±4.394)分,服药信念呈中低水平;服药信念与服药依从性的影响强度呈正相关(r=0.457,P0.01)。结论乳腺癌患者内分泌治疗第1年服药依从性不佳,且与服药信念正相关;乳腺专科护士需要重点关注内分泌治疗人群的护理随访,以提高患者服药依从性。
[Abstract]:Objective to analyze the status of drug compliance and belief in endocrine therapy of breast cancer patients and their correlation. Methods A total of 237 patients with breast cancer received endocrine therapy for the first year after operation in Grade 3A Hospital in Shenyang were selected, and Morisky compliance questionnaire and BMQ drug belief questionnaire were issued. Descriptive and multivariate regression analysis was carried out on the status quo of drug compliance and belief. Results the average score of MMAS-8 questionnaire was 6.39 卤1.68, the average score of drug compliance was -0.02 卤4.394), the average score of drug belief was middle and low, and the influence of drug belief was positively correlated with the intensity of drug compliance (P 0.01). Conclusion the drug compliance of breast cancer patients in the first year of endocrine therapy is not good, and it is positively related to drug taking belief, and breast nurses need to pay attention to the follow-up of endocrine therapy population in order to improve the patients' compliance.
【作者单位】：中国医科大学护理学院人文护理学教研室;中国医科大学附属第一医院护理部;中国医科大学附属第一医院乳腺外科;中国医科大学护理学院社区护理学教研室;华北理工大学护理与康复学院内科护理学教研室;
【基金】：辽宁省科学技术计划(2015225023)
【分类号】：R737.9

【相似文献】